Projection of top global pharmaceutical products by revenue growth 2023

This statistic displays a ranking of the top 10 pharmaceutical products globally based on their projected revenue growth in 2023 compared to the previous year. Novo Nordisk's top product Ozempic is expected to generate an additional revenue of some two billion U.S. dollars compared to 2022.

本统计数据展示了基于2023年预测收入增长率，相较于上一年度，全球前十大药品产品的排名。诺和诺德（Novo Nordisk）的旗舰产品Ozempic预计将比2022年额外创造约二十亿美元的收益。